Lucence TripleRISK: Heart Attack, Stroke & Leukaemia (2025)

Lucence TripleRISK™

Test Name Lucence TripleRISK™
Purpose To assess risk of developing heart attack, stroke and leukaemia.
Test Type Blood Test
Price $2,616 NETT
Appointment Options Same-day appointment (subject to availability).
Book via WhatsApp: 8883 8128 or email: hi@atamed.sg
Clinic Locations Orchard: 1 Orchard Blvd #05-09 Camden Medical Centre, S248649
Tanjong Pagar: 72 Anson Rd #01-02 Anson House, S079911

What Is the Lucence TripleRISK Test?

The Lucence TripleRISK test is a simple blood test that checks for hidden genetic changes linked to a higher risk of heart attack, stroke and leukaemia.

It works by looking for specific mutations, specifically clonal haematopoiesis (CH), in your blood that may develop as you age or due to lifestyle factors, even if you feel completely healthy. By detecting these early changes, TripleRISK helps you take proactive steps to monitor and manage your long-term health.

At ATA Medical, we offer the Lucence TripleRISK blood test at $2,616 NETT, inclusive of GST.

Blood sample labelled Lucence TripleRisk used to assess heart, stroke, and leukaemia risk.

How Does the TripleRISK Test Work?

The Triple RISK test detects clonal haematopoiesis mutations in 11 genes that are commonly linked to ageing and long-term lifestyle factors such as smoking, poor diet or chronic stress. These genes are:

ASXL1, DNMT3A, JAK2, PPM1D, FLT3, IDH2, RUNX1, SF3B1, TET2, TP53, SRSF2

The test measures how much of these mutations are present and calculates your overall risk score for developing the following conditions:

Who Should Consider the TripleRISK Test?

This test is recommended for adults aged 40 to 79 who may have underlying risk factors or personal and family history suggesting elevated risk for cardiovascular or haematological conditions. Suitable individuals include:

  1. Have cardiovascular risk factors such as hypertension, diabetes, high cholesterol or smoking history
  2. Have experienced a heart attack or stroke
  3. Have a family history of leukaemia, myelodysplastic syndromes (MDS), or sudden cardiovascular events
  4. Have previously undergone chemotherapy or radiation therapy
Blood pressure monitor and articles showing heart attack, stroke, and leukaemia risk factors.

It is not recommended for individuals who have had a recent blood transfusion (within the past 2 weeks) or an allogeneic bone marrow transplant. Please consult our doctors beforehand to determine if it is suitable for you.

What Happens After You Receive the Results?

Triple RISK is not a diagnostic tool, but it can help guide further evaluation and preventive strategies. Depending on your score, your doctor may recommend:

  • Closer monitoring and regular follow-up screening (e.g. ECG, echocardiogram, full blood count)
  • Lifestyle changes such as smoking cessation, weight management, improved nutrition and regular exercise
  • Management of underlying conditions such as hypertension or diabetes
Doctor holding human heart model for risk management after TripleRisk blood test screening.

How Much Does the Lucence TripleRisk Test Cost?

At ATA Medical, we offer the TripleRISK test and other related tests. Prices are as follows:

Test Price*
Consultation From $38.15
Lucence TripleRISK Blood Test $2,616
LucenceINSIGHT Liquid Biopsy Cancer Screening (From 5 Cancers) From $1,098
[Optional] Premium Mobile Blood Drawing at Your Home Additional $54.50 (per location up to 5 pax)
Heart Check-Up / Stroke Screening
Apolipoprotein B $32.70
HsCRP $38.15
Lipoprotein (a) $55.59
Fasting Insulin $66.49
Homocysteine $74.12
Essential Lipid Profile:
Full Cholesterol Test (Total, LDL, HDL, Triglycerides, HDL Ratio)
$21.80
Cardiac Screening 3:
Essential Lipid Profile + Apolipoprotein B (ApoB) + HsCRP
$63.22
Cardiac Screening 4:
Cardiac Screening 3 + Homocysteine + Fasting Insulin + Glucose

Note: Fasting is required for accurate results of Fasting Insulin and Glucose.
$172.22
Electrocardiogram (ECG) From $49.05
2D Echocardiogram** $436
CT Coronary Angiogram From $1,329.80
CT Calcium Score Test From $381.50
Ultrasound Carotid Intima-Media Thickness (CIMT) Test From $163.50
Brain CT Scan From $577.70
Brain MRI Scan From $1,068.20
*Prices are NETT and inclusive of GST.
**2D Echocardiogram will be done at the cardiologist clinic and reviewed by the cardiologist.

How Long Does the TripleRISK Test Take?

A blood test at our clinic typically takes 30 to 60 minutes during off-peak periods. Results for the TripleRISK test are usually available within 12 working days, and your doctor will contact you by phone or email to explain the findings.

How to Prepare for the TripleRISK Test?

Before taking the TripleRISK blood test, certain steps may help ensure more precise results:

  • It is generally advised to avoid heavy meals for at least 4 hours before your appointment.
  • If you have had a recent blood transfusion (within the past 2 weeks) or an allogeneic bone marrow transplant, the test may not be suitable.

Please follow any specific instructions provided by your doctor or the clinic team prior to your test.

How to Book an Appointment for the Lucence TripleRISK Test?

ATA Medical @ Orchard

Address: 1 Orchard Blvd, #05-09 Camden Medical Centre, Singapore 248649
Nearest MRT: Orchard Boulevard Station (TE13)
Contact Number: 6223 0682
Email: camden@atamed.sg
Opening Hours:
Mon - Fri: 8:30 AM to 12:30 PM, 1:30 PM to 5:30 PM
Sat: 8:30 AM to 12:30 PM
Sun & PH: Closed

ATA Medical @ Tanjong Pagar

Address: 72 Anson Rd, #01-02 Anson House, Singapore 079911
Nearest MRT: Tanjong Pagar Station (EW15)
Contact Number: 6223 0682
Email: hi@atamed.sg
Opening Hours:
Mon - Fri: 8:30 AM to 12:30 PM, 1:30 PM to 5:30 PM
Sat: 8:30 AM to 12:30 PM
Sun & PH: Closed

Navigate to Us

ATA Medical (Anson House)

Nearest MRT: EW15 Tanjong Pagar

ATA Medical (Camden Medical Centre)

Nearest MRT: TE13 Orchard Boulevard

Frequently Asked Questions (FAQ)

At ATA Medical, we offer LucenceINSIGHT liquid biopsy tests to screen for up to 50 different cancer types beyond TripleRISK. These tests range from targeted 5-cancer panels to broader multi-cancer options. The most suitable test depends on your medical history, risk factors and screening goals. Consult our doctor to help determine whether these tests are appropriate for your needs.
The TripleRISK test helps assess your future risk of developing heart attack, stroke or leukaemia by detecting clonal haematopoiesis mutations in your blood. These mutations become more common with age and may indicate hidden risk not captured by conventional screening. The test is especially relevant for individuals aged 40 to 79 or those with a personal or family history of cardiovascular or blood-related conditions.
The TripleRISK test is currently not MediSave-claimable and is generally not covered by standard health insurance in Singapore. However, coverage may vary depending on your insurer, policy type or corporate benefits. It is best to check directly with your insurance provider regarding possible reimbursement.
Yes, the TripleRISK test can be done alongside other cardiovascular, cancer-related or general health screening packages offered at ATA Medical. It may also be combined with additional blood tests, imaging scans or ECGs for a more comprehensive assessment. It is advisable to consult a doctor to determine which screenings and tests are most appropriate based on your risk factors and health concerns.
Fasting is not strictly required before the TripleRISK test, but it is generally advised to avoid heavy meals for at least 4 hours before your appointment. This helps reduce variability in blood content that could potentially affect sample quality. If you are doing other fasting blood tests on the same day, your doctor may recommend fasting beforehand to accommodate both tests. Always follow the clinic’s instructions before your visit.
The TripleRISK test is a genetic blood test that detects clonal haematopoiesis mutations linked to the risk of heart attack, stroke and leukaemia, while routine blood tests or cholesterol screening assess general health markers such as blood counts or lipid levels. TripleRISK identifies age-related genetic changes not typically captured by standard tests. If you are unsure, consulting our doctors can help determine whether it adds value to your risk assessment.
Yes, the TripleRISK test can be considered even if you have no symptoms or known family history, as clonal haematopoiesis mutations may develop silently with age. The test is designed for risk assessment rather than diagnosis and may be relevant for proactive screening. Consulting our doctors can help determine if the test is appropriate based on your health profile and goals.
If you have an elevated TripleRISK score, your doctor may recommend repeating the test annually or once every few years depending on your result category and clinical context. Repeat testing can help monitor changes in clonal mutation levels over time.
The TripleRISK test is generally recommended for adults aged 40 to 79, as clonal haematopoiesis becomes more prevalent with age. While it can technically be performed on younger individuals, its clinical value in that group may be limited. Consulting our doctors can help assess whether early testing is relevant based on your risk factors or medical history.
A high TripleRISK score suggests a significantly increased likelihood of developing heart attack, stroke or leukaemia in the future due to detectable clonal mutations. While it does not confirm disease, it may warrant closer monitoring, lifestyle modifications and additional screening. Your doctor will recommend appropriate next steps, which may include regular screenings or targeted lifestyle changes based on your overall health profile.
Yes, ATA Medical offers an optional mobile blood draw service for the TripleRISK test, suitable for individuals who prefer home-based collection. This service is subject to availability and incurs an additional fee of $54.50 per location for groups of up to 5 persons. Contact us to check availability and schedule a home-based appointment.